Ovarian cancer cells treated with a neutralizing anti-STC-1 monoclonal antibody exhibit higher apoptosis rates than control cells.207 In a mouse model of human lung cancer, targeting STC-1-expressed tumor cells exhibits efficient antitumor effects.208. Here, STC1 is linked to ovarian carcinoma.